Dual Gene Therapy Has Beneficial Effects On Blood Biomarkers And Muscle Composition

Dual Gene Therapy Has Beneficial Effects On Blood Biomarkers And Muscle Composition

In April 2016 BioViva USA Inc. published a press release stating that Elizabeth Parrish, CEO, had experienced telomere lengthening in her leukocytes, as a result of an injection of two experimental therapies. These consisted of a myostatin inhibitor to protect against loss of muscle mass with age, and a telomerase inducer to battle stem cell depletion responsible for diverse age-related diseases and infirmities.

Read More

One Year Anniversary Of Bioviva's Gene Therapy Against Human Aging

One Year Anniversary Of Bioviva's Gene Therapy Against Human Aging

It has officially been one year since I volunteered to take the first gene therapy to treat biological aging. It has been an amazing year! It began with a great deal of excitement in the weeks leading up to taking the treatment. The excitement of treatment day was followed by months of anticipation, while unfortunately we have not yet succeeded in undoing all aspects of aging just yet, we have gathered tantalizing human data for the first time in history. 

Read More

Bioviva, Gene Therapy And Blockchain Merges In Russia

Bioviva, Gene Therapy And Blockchain Merges In Russia

During June 20th to the 23rd, founder and CEO of BioViva USA Inc, Elizabeth Parrish visited Moscow at the invitation of board member of the Blockchain Community and founder of Future Fintech accelerator, Alex Fork.  As a result of the meeting an announcement was made with BioViva to open an outreach office in Russia. Additionally, an agreement to implement a crowd investing campaign for BioViva using the Waves Blockchain platform was made.

Read More

Bioviva Talks At The 2b Ahead Thinktank Future Congress In Germany

Bioviva Talks At The 2b Ahead Thinktank Future Congress In Germany

The 2b AHEAD ThinkTank Future Congress ranks as one of the most attractive events in the European innovation scene. For the last 15 years, 300 leading figures in business and society have gathered annually discuss the future of business, with guests including executive directors and CEOs, innovation managers, marketing leaders, extreme lead users, and innovative entrepreneurs. 2016’s annual congress was exclusively focused on future forecasts, speed and agility being a major driver of growth today.

Read More

Deep Knowledge Life Sciences And Bioviva Announce Partnership

Deep Knowledge Life Sciences And Bioviva Announce Partnership

“BioViva aims to make gene therapy affordable to everyone. Dmitry Kaminskiy, the founding partner of Deep Knowledge Life Sciences, is enthusiastically funding gene therapy, and is himself an early adopter”, said BioViva CEO Elizabeth Parrish, adding “We both want to see a world where investors actually live their legacy instead of just leaving it”, alluding to a possible future trend.

Read More

Alzheimer’s Cure

Alzheimer’s Cure

There are telomere lengthening compounds available right now for use in research labs. They are not currently available for human use. A group of scientists wants to test these compounds on aging humans now to see if the telomere lengthening effects will induce meaningful age reversal effects.

Telomeres in our cells shorten as we grow older and create cellular havoc that predisposes us to multiple age-related pathologies. These experimental enzymes promote telomere lengthening and in the process offer an intriguing opportunity to circumvent biological aging processes.

Read More

The Telomeres-P53-pgc Aging Axis

The Telomeres-P53-pgc Aging Axis

This 2011 paper by Dr DePinho builds on previous papers and his theory of the “telomere-p53-PGC axis”. This is a big reason along with the work of Dr Michael Fossel I believe telomerase therapy is probably the best chance of radical life extension in the near future. This is one of a number of papers that implicate dysfunctional telomeres in a cascade that causes mitochondrial dysfunction and various other aging consequences.

Read More